Literature DB >> 26840135

The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.

Lynn C Hartmann, Noralane M Lindor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26840135     DOI： 10.1056/NEJMra1503523

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  81 in total

1.  Targeting progesterone signaling prevents metastatic ovarian cancer.

Authors:  Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-01       Impact factor: 11.205

Review 2.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

Review 3.  Precision reproductive medicine: multigene panel testing for infertility risk assessment.

Authors:  Stephen C Collins
Journal:  J Assist Reprod Genet       Date:  2017-05-03       Impact factor: 3.412

4.  Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes.

Authors:  Dana Sherill-Rofe; Dolev Rahat; Steven Findlay; Anna Mellul; Irene Guberman; Maya Braun; Idit Bloch; Alon Lalezari; Arash Samiei; Ruslan Sadreyev; Michal Goldberg; Alexandre Orthwein; Aviad Zick; Yuval Tabach
Journal:  Genome Res       Date:  2019-02-04       Impact factor: 9.043

5.  Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.

Authors:  Rachel Shapira; Erin Turbitt; Lori H Erby; Barbara B Biesecker; William M P Klein; Gillian W Hooker
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

6.  RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.

Authors:  Emma Nolan; François Vaillant; Daniel Branstetter; Bhupinder Pal; Göknur Giner; Lachlan Whitehead; Sheau W Lok; Gregory B Mann; Kathy Rohrbach; Li-Ya Huang; Rosalia Soriano; Gordon K Smyth; William C Dougall; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2016-06-20       Impact factor: 53.440

7.  Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.

Authors:  Hidetaka Nomura; Masayuki Sekine; Shiro Yokoyama; Masami Arai; Takayuki Enomoto; Nobuhiro Takeshima; Seigo Nakamura
Journal:  Int J Clin Oncol       Date:  2019-05-04       Impact factor: 3.402

8.  Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.

Authors:  James W Jakub; Anne Warren Peled; Richard J Gray; Rachel A Greenup; John V Kiluk; Virgilio Sacchini; Sarah A McLaughlin; Julia C Tchou; Robert A Vierkant; Amy C Degnim; Shawna Willey
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

Review 9.  Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.

Authors:  Ismail Jatoi
Journal:  Eur J Breast Health       Date:  2018-10-01

10.  Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer.

Authors:  Juhua Luo; Michael Hendryx; JoAnn E Manson; XiaoYun Liang; Karen L Margolis
Journal:  J Clin Endocrinol Metab       Date:  2016-07-26       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.